Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ISOLEUCINE INDUSTRY
2.1 Summary about Isoleucine Industry
2.2 Isoleucine Market Trends
2.2.1 Isoleucine Production & Consumption Trends
2.2.2 Isoleucine Demand Structure Trends
2.3 Isoleucine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Food Grade
4.2.2 Feed Grade
4.2.3 Pharmaceutical Grade
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Food
4.3.2 Feed
4.3.3 Pharmaceuticals
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Food Grade
5.2.2 Feed Grade
5.2.3 Pharmaceutical Grade
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Food
5.3.2 Feed
5.3.3 Pharmaceuticals
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Food Grade
6.2.2 Feed Grade
6.2.3 Pharmaceutical Grade
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Food
6.3.2 Feed
6.3.3 Pharmaceuticals
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Food Grade
7.2.2 Feed Grade
7.2.3 Pharmaceutical Grade
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Food
7.3.2 Feed
7.3.3 Pharmaceuticals
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Food Grade
8.2.2 Feed Grade
8.2.3 Pharmaceutical Grade
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Food
8.3.2 Feed
8.3.3 Pharmaceuticals
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Food Grade
9.2.2 Feed Grade
9.2.3 Pharmaceutical Grade
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Food
9.3.2 Feed
9.3.3 Pharmaceuticals
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Evonik
10.1.2 Ajinomoto Group
10.1.3 KYOWA
10.1.4 Tianjin Tianan Pharmaceuticals
10.1.5 Hubei Bafeng Pharmaceutical
10.1.6 Jinghai Amino Acid
10.1.7 Jiahe Biotech
10.1.8 JIRONG PHARM
10.1.9 JiangsuShenhua Pharmaceutical
10.1.10 YichangSanxiaPharmaceutical
10.1.11 ZhangjiagangxingyuTechnology
10.1.12 MeihuaGroup
10.1.13 Maidan Biology
10.2 Isoleucine Sales Date of Major Players (2017-2020e)
10.2.1 Evonik
10.2.2 Ajinomoto Group
10.2.3 KYOWA
10.2.4 Tianjin Tianan Pharmaceuticals
10.2.5 Hubei Bafeng Pharmaceutical
10.2.6 Jinghai Amino Acid
10.2.7 Jiahe Biotech
10.2.8 JIRONG PHARM
10.2.9 JiangsuShenhua Pharmaceutical
10.2.10 YichangSanxiaPharmaceutical
10.2.11 ZhangjiagangxingyuTechnology
10.2.12 MeihuaGroup
10.2.13 Maidan Biology
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT